BlackRock Fund Advisors - KALOBIOS PHARMACEUTICALS INC ownership

KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 36 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of KALOBIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$64,000
-40.2%
131,165
+111.4%
0.00%
Q4 2014$107,000
+137.8%
62,043
+114.6%
0.00%
Q3 2014$45,000
-36.6%
28,916
-6.8%
0.00%
Q2 2014$71,000
-91.9%
31,024
-90.4%
0.00%
Q1 2014$880,000
-36.9%
324,571
+2.9%
0.00%
Q4 2013$1,395,000
+21.5%
315,574
+24.3%
0.00%
Q3 2013$1,148,000
-9.6%
253,977
+13.2%
0.00%
Q2 2013$1,270,000224,3580.00%
Other shareholders
KALOBIOS PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,632,928$11,901,0003.36%
DAFNA Capital Management LLC 250,000$1,130,0001.23%
WALL STREET ASSOCIATES 625,200$2,826,0000.26%
Lehman Brothers Holdings Inc. 942,092$4,258,0000.20%
Old West Investment Management, LLC 54,517$246,0000.12%
WEXFORD CAPITAL LP 278,460$1,259,0000.10%
CLOUGH CAPITAL PARTNERS L P 400,000$1,808,0000.06%
SABBY MANAGEMENT, LLC 105,408$476,0000.03%
PRIMECAP MANAGEMENT CO/CA/ 4,706,675$21,274,0000.03%
TUDOR INVESTMENT CORP ET AL 125,000$565,0000.02%
View complete list of KALOBIOS PHARMACEUTICALS INC shareholders